Scientific Program
Wednesday
January 25th, 2006
14h00 - 18h00:
Keynote session
Gregg L.
Semenza (Institute for
Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore,
USA):
Keynote: Hypoxia
Signal Transduction in Health and Disease
Michael B.
Yaffe (Center for Cancer
Research, Department of Biology
Massachusetts
Institute of Technology, Cambridge, MA, USA):
Phosphoserine/threonine-binding
domains: Integrators of protein kinase signaling pathways in cell cycle control
and cancer
Mathieu
Bollen (Afdeling
Biochemie, Faculteit Geneeskunde, Katholieke Universiteit Leuven, Leuven,
Belgium):
title to be
announced
Jurg Tschopp (Department of Biochemistry, University
of Lausanne, BIL Biomedical Research Center, Epalinges, Switzerland):
Conserved
signaling mechanisms in plant and vertebrate innate immunity
Roger J.
Davis (Howard Hughes
Medical Institute, UMASS Medical School, Worcester, USA):
Signal
transduction by stress-activated MAP kinases
Thursday
January 26th, 2006 (Morning session)
8h30 - 10h30:
Receptor signaling
Richard W.
Padgett (Waksman
Institute, Rutgers University, Piscataway, USA):
TGFbeta Growth
Control
Walter
Birchmeier (Max-Delbruck-Center
for Molecular Medicine, Berlin, Germany):
The role of
Met-Gab1 Signalling in vivo.
Ulf R. Rapp (Institut fuer Medizinische
Strahlenkunde und Zellforschung (MSZ), Wuerzburg, Germany):
title to be
announced
Johannes L.
Bos (Dept of
Physiological Chemistry, Utrecht, The Netherlands):
title to be
announced
11h00 - 13h00:
Protein kinase cascades as therapeutic targets
Dario Alessi (MRC Protein Phosphorylation Unit,
School of Life Sciences, MSI/WTB Complex, University of Dundee, Scotland):
title to be
announced
Jacques
Pouysségur (Institute of
Signaling, Developmental Biology and Cancer Research CNRS UMR 6543, Centre A.
Lacassagne, Nice, France):
Nutrient stress
signaling and tumor progression
Brian
Hemmings (Friedrich
Miescher Institute for Biomedical Research, Basel, Switzerland):
Human nuclear
Dbf2-related kinases (NDRs) are up-regulated in cancer
Laurent
Meijer (CNRS, Roscoff,
France):
Multiple
intracellular effects of pharmacological inhibitors of cyclin-dependent kinases
Ying Xia (Center for Environmental Genetics and
Department of Environmental Health, University of Cincinnati Medical Center,
Cincinnati, USA):
title to be
announced
Thursday
January 26th, 2006 (Afternoon session)
16h00 - 18h30:
Cell death in cancer
Caroline Dive (Cellular and Molecular Pharmacology
Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust,
Manchester, United Kingdom):
title to be
announced
Peter H.
Krammer (Tumorimmunology
Program, German Cancer Research Center, Heidelberg, Germany):
Signaling of
life and death in T cells
Guido Kroemer (CNRS, UMR8125, Institut Gustave Roussy,
Villejuif, France):
Mechanisms of
caspase-independent cell death
Gerry Melino (Biochemistry Laboratory, Department of
Experimental Medicine, University of Rome Tor Vergata, Rome, Italy):
title to be
announced
Sidhartha Ray (Arnold & Marie Schwartz College of
Pharmacy & Health Sciences
Div. of
Pharmaceutical Scs/Long Island University, Brooklyn, NY, USA):
How Antitoxic
and Anticancer signals Maneuver Programmed and Unprogrammed Cell Death In Vivo?
Jean Edouard
Dumont (Institut de
Recherche Interdisciplinaire (IRIBHM), Universite Libre de Bruxelles (ULB),
Belgique):
Molecular
Biology of Thyroid Cancer
Friday January
27th, 2006 (Morning session)
8h30 - 10h30:
Inflammation specific signaling
Bharat B.
Aggarwal (Cytokine
Research Section, The University of Texas M. D. Anderson Cancer Center,
Houston, USA):
Targeting
Inflammatory Cell signaling pathway for Prevention and Treatment of cancer
Mark Ginsberg (Department of Medicine, University of
California San Diego, La Jolla, CA, USA):
Integrin
Signaling in Cancer and Inflammation
Moncef Zouali (INSERM U606, Centre Viggo Petersen, Hôpital
Lariboisière,
Paris, France):
Signaling
pathways in systemic autoimmune diseases: Toward novel opportunities for
therapeutic targeting
Irfan Rahman (Department of Environmental Medicine,
Lung Biology and Disease Program, University of Rochester Medical Center,
Rochester, NY, USA):
Regulation of
inflammation and glucocorticoid signaling by curcumin and resveratrol
Lina Ghibelli (University Tor Vergata, Rome, Italy):
title to be
announced
11h00 - 13h00:
Cell signaling in health and disease
Bernd Groner (Georg-Speyer-Haus, Institute for
Biomedical Research, Frankfurt am Main, Germany):
Signaling events
in mammary epithelial cell differentiation and breast cancer
Anna
Krichevsky (Center for
Neurologic Diseases, Brigham and Women's Hospital
Harvard Medical
School, Boston, USA):
A role of
microRNAs in brain tumors (preliminary title)
Dominique
Stehelin (CNRS UMR 8526,
Institut de Biologie de Lille, France):
New steps toward
the use of parvovirus H1 as a therapeutic anti-cancer drug.
John Hiscott (Molecular Oncology Group Lady Davis
Institute for Medical Research, Jewish General Hospital, Montreal, Canada):
TLR-dependent
and -independent pathways leading to the interferon antiviral response
Friday January
27th, 2006 (Afternoon session)
16h00 - 18h30:
Cell signaling pathways leading to regulated chromatin modifications
Richard
Pestell (Lombardi
Comprehensive Cancer Center, Georgetown University, Washington, USA):
"Cyclins
and cdks": Target for Cancer Therapy
François Fuks (Free University of Brussels, Faculty of
Medicine, Laboratory of Molecular Virology, Brussels, Belgium) :
Mechanisms of
DNA methylation in mammals
Luciano Di
Croce (ICREA and Centre
de Regulacio Genomica (CRG), Barcelona, Spain):
title to be
announced
Willem
Voncken (Research
Institute Growth and Development, University Maastricht, The Netherlands):
title to be
announced
Guy Haegeman (Laboratory for Eukaryotic Gene
Expression and Signal Transduction, Department of Molecular Biology, Ghent
University, Belgium):
Chromatin impact
on NFkB-driven gene expression
Saturday
January 28th, 2006 (Morning session)
8h30 - 10h30:
Transcriptional control
Yinon
Ben-Neriah (The
Lautenberg Center for Immunology, Hebrew-University-Hadassah Medical School,
Jerusalem, Israel):
title to be
announced
Sankar Ghosh (Yale University School of Medicine, New
Haven, CT , USA):
title to be
announced
Moshe Oren (Department of Molecular Cell Biology,
The Weizmann Institute, Rehovot, Israel):
Oncogenic
signaling by mutant p53
11h00 - 13h00:
Transcriptional control
Young-Joon
Surh (National Research
Laboratory of Molecular
Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National
University, South Korea):
Redox-Sensitive
Transcription Factors as Prime Targets for Chemoprevention and Cyoprotection
Iris Behrman (University of Luxembourg):
title to be
announced
Jacques
Piette (Laboratory of
Virology & Immunology, Institute of Pathology B23, University of Liege,
Liege, Belgium):
The posphatase
SHIP-1 is an important mediator in the oxidative stress-induced NF-kB
activation.
Peter Angel (Deutsches Krebsforschungszentrum, DKFZ,
Division of Signal Transduction and Growth Control, Heidelberg, Germany):
Regulation of
gene expression in skin remodeling and tumourigenesis
13h00: End of
the meeting